Evidence map›Paper›PMID 41671322›Full record

ArticlePLoS pathogens2026

A humanized IFN-γ mouse model reveals skin eschar formation, enhanced susceptibility and scrub typhus pathogenesis.

Ryan H Cho, Lihai Gao, Hui Wang, Yixuan Zhou, Casey Gonzales, Dario Villacreses, Emmett A Dews, Xiaofei Zhou, Ruili Lv, Hema P Narra and 2 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ryan H ChoDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Lihai GaoDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Hui WangDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Yixuan ZhouDepartment of Neurology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Casey GonzalesDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Dario VillacresesDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Emmett A DewsDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Xiaofei ZhouBiocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China.
Ruili LvBiocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China.
Hema P NarraDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Lynn SoongDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Yuejin LiangDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.ORCID https://orcid.org/0000-0002-9557-1847

Funding

Pathogenic Mechanisms of Vascular Dysfunction in Scrub TyphusR01AI132674 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Yuejin Liang, LYNN SOONG · 2018 to 2026
$3.0M
Pre-clinical studies to repurpose FDA-approved adenosine A2A receptor antagonists for lethal rickettsial infectionR01AI184781 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Bin Gong, Yuejin Liang · 2025 to 2026
$927k
Generation of Orientia tsutsugamushi mutant strains for pathogenesis researchR61AI179997 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Hema Prasad Narra, LYNN SOONG · 2024 to 2026
$833k
NIAID NIH HHS R01 AI132674NIAID NIH HHS R01 AI184781NIAID NIH HHS R61 AI179997
6 · The paper itself

Abstract

Scrub typhus, caused by Orientia tsutsugamushi (Ot) bacteria, is a serious acute febrile illness associated with significant mortality. No effective vaccine is currently available, largely due to the complex Ot strain diversity and an incomplete understanding of protective immune mechanisms. To overcome these challenges, there is a critical need for a suitable animal model that mimics human disease through the natural route of infection. Here, we report for the first time that a genetically engineered humanized mouse strain (with triple knockout/knock-in of IFN-γ and its receptors, abbreviated as hIFNG/hIFNGR), exhibits increased susceptibility to intradermal Ot infection compared to wild-type (WT) mice. This is evidenced by greater body weight loss, elevated bacterial burden, and reduced expression of interferon-stimulated genes (ISGs). hIFNG/hIFNGR mice exhibit pronounced biochemical abnormalities and tissue pathology accompanied by dysregulated T cell and neutrophil responses following infection. Notably, this novel mouse strain with human IFN-γ signaling can develop skin eschar-like lesions resembling those observed in human patients. Overall, our study introduces a promising mouse model to dissect the immunopathogenesis of scrub typhus and evaluate future vaccine candidates.

Indexed as

Disease Models, AnimalInterferon-gammaOrientia tsutsugamushiScrub TyphusSkinAnimalsDisease SusceptibilityFemaleHumansInterferon gamma ReceptorMiceMice, KnockoutMice, TransgenicReceptors, InterferonInterferon-gammaInterferon gamma ReceptorReceptors, Interferon

Identifiers

PMID41671322
PMCPMC12912700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.